Clinical Trial Update: HEALEY ALS Platform Trial - Regimen G DNL343 [Phase 2, Phase 3]

View source ↗

Summary

Results from the HEALEY ALS Platform Trial Regimen G evaluating DNL343 in amyotrophic lateral sclerosis have been posted after completion of Phase 2/3 evaluatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• DNL343

Snippet

Sponsor: Merit E. Cudkowicz, MD | Conditions: Amyotrophic Lateral Sclerosis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2026-01-28